Literature DB >> 9626130

Treatment of estrogen deficiency symptoms in women surviving breast cancer. The Hormone Foundation, Canadian Breast Cancer Research Initiative, National Cancer Institute of Canada, Endocrine Society, and the University of Virginia Cancer Center and Woman's Place.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9626130     DOI： 10.1210/jcem.83.6.4934

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  4 in total

Review 1.  Hot flashes: aetiology and management.

Authors:  D Barton; C Loprinzi; D Wahner-Roedler
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

2.  Levetiracetam for the treatment of hot flashes: a phase II study.

Authors:  Susan Thompson; Aditya Bardia; Angelina Tan; Debra L Barton; Lisa Kottschade; Jeff A Sloan; Brad Christensen; DeAnne Smith; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2007-06-28       Impact factor: 3.603

Review 3.  Risks and benefits of hormone replacement therapy: the evidence speaks.

Authors:  Karin H Humphries; Sabrina Gill
Journal:  CMAJ       Date:  2003-04-15       Impact factor: 8.262

4.  Menopausal hormone therapy after breast cancer.

Authors:  Graham A Colditz
Journal:  Breast Cancer Res       Date:  2005-06-01       Impact factor: 6.466
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.